Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
07/11/2018 07/12/2018 07/13/2018 07/16/2018 07/17/2018 Date
96.15(c) 98.2(c) 97.65(c) 97.9(c) 96.5 Last
41 601 42 177 29 778 36 696 68 272 Volume
+0.26% +2.13% -0.56% +0.26% -1.43% Change
More quotes
Financials (EUR)
Sales 2018 689 M
EBIT 2018 210 M
Net income 2018 157 M
Finance 2018 176 M
Yield 2018 1,03%
Sales 2019 750 M
EBIT 2019 232 M
Net income 2019 170 M
Finance 2019 295 M
Yield 2019 1,13%
P/E ratio 2018 34,78
P/E ratio 2019 31,50
EV / Sales2018 7,68x
EV / Sales2019 6,89x
Capitalization 5 463 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
07/03DIASORIN : Conclusion treasury shares buy-back plan
PU
07/03DIASORIN : Allegato 3F (acquisto azioni proprie luglio 2018)
PU
07/03DIASORIN : Allegato 3F (acquisto azioni proprie giugno 2018)
PU
07/03DIASORIN : Report treasury shares buy-back
PU
06/29DIASORIN : Weekly report treasury shares buy-back
PU
06/20DIASORIN : Kicks off Year-long Virtual Resource Center, Complete with Educationa..
AQ
06/12DIASORIN INTRODUCES PRIMER PAIR REAG : Anaplasma phagocytophilum, ehrlichia and ..
PU
06/08DIASORIN : Weekly report treasury shares buy-back
PU
06/04DIASORIN : Allegato 3F (acquisto azioni proprie maggio 2018)
PU
06/01DIASORIN : Weekly report treasury shares buy-back
PU
More news
Sector news : Diagnostic & Testing Substances
07/11Brazil prosecutors allege jailed GE executive helped company partake in medic..
RE
07/11MEDTRONIC : Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure
DJ
07/09BECTON DICKINSON AND : Completes Acquisition of TVA Medical
DJ
06/29ESSILOR INTERNATIONAL : Luxottica, Essilor extend deadline for merger pending Ch..
RE
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
More sector news : Diagnostic & Testing Substances
Latest Tweets
07/03DiaSorin : Conclusion treasury shares buy-back plan  
07/03DiaSorin : Report treasury shares buy-back  
06/29DiaSorin : Weekly report treasury shares buy-back  
06/27Jefferies Financial Group Sets DiaSorin FY2018 Earnings Estimates at $3.56 EP.. 
06/01DiaSorin : Weekly report treasury shares buy-back  
More tweets
Qtime:31
News from SeekingAlpha
03/08Diasorin SPA ADR 2017 Q4 - Results - Earnings Call Slides 
2017Diasorin SPA ADR 2017 Q3 - Results - Earnings Call Slides 
2017DiaSorin (DSRLF) Investor Presentation - Slideshow 
2016Winner And Losers Among Italian Companies 
2016Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides 
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 82,2 €
Spread / Average Target -16%
EPS Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Chen Menachem Even Executive Director & Chief Commercial Officer
Franco Moscetti Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA32.30%6 401
BIOMÉRIEUX3.49%10 678
AUTOBIO DIAGNOSTICS CO LTD55.60%5 208
MACCURA BIOTECHNOLOGY CO LTD--.--%2 245
SIEGFRIED HOLDING AG26.85%1 743
GETEIN BIOTECH INC34.77%1 609